Don’t Miss these Stocks: HighPoint Resources Corporation (NYSE:HPR), EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

HighPoint Resources Corporation (NYSE:HPR):

Important Stats for Investors:

HighPoint Resources Corporation (NYSE:HPR) shares dropped -2.06 percent and closed the day at $5.23. The company has its outstanding shares of 208.17 Million. The Relative Volume value measured for HighPoint Resources Corporation stands at 0.66. A total of 1.13 Million shares exchanged at hands and its Average Volume is 1.69 Million. Its 52-week high and low range is $7.6 and $0.01, respectively. The company has a market cap of $1.09 Billion.

The SMA20 for the stock is at 1.45 percent, SMA50 stands at -11.8 percent, while SMA200 is -7.91 Percent, according to Finviz reported data. Return on Assets (ROA) value of the stock is -10.4 Percent. The Return on Equity (ROE) and Return on Investment (ROI) values are -22.4 percent and -6 percent respectively.

The stock currently shows its YTD (Year to Date) performance of 1.95 percent, whereas its Weekly performance stands at -3.15%. The Monthly and Yearly performances are -14.4 percent and 58.48 percent respectively.

Profitability and Ratings Review:

Profitability analysis greatly helps in making investment decision. Net profit margin of HighPoint Resources Corporation (NYSE:HPR) was recorded at -52.1 percent, operating profit margin was -3 percent, while gross profit margin stands at 83.9 percent. Beta factor was calculated at 3.3.

Looking at the Analyst Recommendations of the stock, 3 Analysts issued a Buy for MoSys, 5 gave Outperform, 3 analysts gave Hold Rating, 0 issued Underperform and 0 marked the stock as Sell.

Future Expectations:

The company’s Average Earnings Estimate for the Current Fiscal quarter is $0.04, according to consensus of 10 analysts. They are also projecting the Low EPS estimate of $0.01 and the High EPS estimate of $0.08.

The company’s Average Revenue Estimate for the current quarter is $123.76 Million, while Low and High Revenue Estimates are $113.87 Million and $138.2 Million respectively. These Revenue projections are a consensus of 7 Analysts.

Volatility Analysis:

Volatility is a key factor to observe. When we see the company’s Volatility, it currently has a monthly volatility of 5.25% and weekly volatility of 4.85%.

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT):

Last Day Trading Summary:

The Company ended its previous trading session at $2.32 with the gain of 9.43%. The market capitalization of the company is $121.29 Million. Overall, 1.12 Million shares exchanged hands versus its average volume of $260.37 Million. EyePoint Pharmaceuticals, Inc. currently has its 52-Week High range of $2.88, while its 52-week low range is $0.93. The Price to Sales (P/S) of the company is 41.82, while P/B (Price to Book) stands at 12.89. By looking at the Volatility of the company, Week Volatility is at 4.73%, whereas Month Volatility stands at 4.65%.

Analysts Coverage:

Looking at Recommendation Trends of the stock polled by Reuters. For the Current month, 0 analysts have assigned this stock as Buy where 3 assigned Outperform, 0 analysts believe it’s a Hold, 0 said Underperform and only 0 assigned Sell rating.

For the current Fiscal Quarter, 4 analysts on average are expecting earnings of $-0.13 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.15 whereas, High Estimate is $-0.11

According to 4 analysts, the Average Revenue Estimate is $720000 for the current Fiscal quarter. The Low Revenue estimate is $640000, while High Revenue estimate is $850000.